Posted in | News | LEDs

Osram and Seoul Semiconductor Create Patent Cross Licence Agreement

OSRAM (Germany) has granted to Seoul Semiconductors against compensation a license to manufacture and sell white LEDs with conversion technology using patents owned by the OSRAM subsidiary OSRAM Opto Semiconductors. In return Seoul Semiconductors granted to OSRAM a license to use housing patents of Seoul Semiconductors. This agreement paves the way for a closer cooperation between the two companies.

Conversion technology was developed by OSRAM Opto Semiconductors. It enables the production of white LEDs using blue emitting InGaN (Indium Gallium Nitride) based chips and suitable fluorescent converter. With the agreement signed today Seoul Semiconductors is granted the right to use this OSRAM intellectual property in white LEDs of all sizes, in all output categories and for all areas of application. OSRAM has signed royalty bearing license agreements with various companies - for example Rohm, Everlight, Lite-On, Harvatek Vishay, Samsung Electrics, Yashin and Citizen.

Dr. Rüdiger Müller, CEO of OSRAM Opto Semiconductors: “Over the years, OSRAM Opto Semiconductors has built up a very strong patent position. It is the foundation of our strong market position.” “Today´s agreement is a perfect example for a productive and fair collaboration. But we will also continue to vigorously enforce our patent rights against companies making unauthorized use of our intellectual property. International courts have ruled on our favour in many cases.” stated Gerd Pokorny, Senior Vice President, OSRAM GmbH.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.